Effects of streptozotocin on glucose metabolism, insulin response, and adiposity in ob ob mice

Bruce R. Batchelor, Judith S. Stern, Patricia R. Johnson, Richard J. Mahler

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

To determine whether hyperglycemia in the obese hyperglycemic ( ob ob) mouse is related to enhanced activity of the pancreatic beta cell, streptozotocin (175 mg/kg) was injected into lean and ob ob mice at 8 wk of age. The influence of this injection upon glucose metabolism, adipose cellularity, pancreatic morphology and immunoreactive insulin (IRI) release from isolated pancreatic islets was measured. The plasma glucose levels before and after an oral glucose load were elevated in lean and decreased in ob ob mice 2 wk after treatment with streptozotocin. By 5 wk after this treatment, a reduced pancreatic islet size, beta cell number and a decreased pancreatic islet IRI release were present in both lean and ob ob mice. At this time, plasma glucose was still elevated in lean, but depressed in ob ob mice and the insulin responsiveness in muscle and adipocytes was unchanged. Hyperglycemia abates in the ob ob mouse as hypersecretion of insulin is diminished, but these observations may not be directly related, since streptozotocin affects key metabolic activities of the liver as well as the pancreatic beta cell. The progression of obesity and status of adipose cellularity are not directly related to hyperinsulinemia, since they are not altered following streptozotocin treatment.

Original languageEnglish (US)
Pages (from-to)77-91
Number of pages15
JournalMetabolism
Volume24
Issue number1
DOIs
StatePublished - 1975
Externally publishedYes

Fingerprint

Adiposity
Streptozocin
Insulin
Glucose
Islets of Langerhans
Insulin-Secreting Cells
Hyperglycemia
Hyperinsulinism
Adipocytes
Therapeutics
Obesity
Cell Count
Muscles
Injections
Liver

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Effects of streptozotocin on glucose metabolism, insulin response, and adiposity in ob ob mice. / Batchelor, Bruce R.; Stern, Judith S.; Johnson, Patricia R.; Mahler, Richard J.

In: Metabolism, Vol. 24, No. 1, 1975, p. 77-91.

Research output: Contribution to journalArticle

Batchelor, Bruce R. ; Stern, Judith S. ; Johnson, Patricia R. ; Mahler, Richard J. / Effects of streptozotocin on glucose metabolism, insulin response, and adiposity in ob ob mice. In: Metabolism. 1975 ; Vol. 24, No. 1. pp. 77-91.
@article{93659747b8214b9394dc90cbc4cc3700,
title = "Effects of streptozotocin on glucose metabolism, insulin response, and adiposity in ob ob mice",
abstract = "To determine whether hyperglycemia in the obese hyperglycemic ( ob ob) mouse is related to enhanced activity of the pancreatic beta cell, streptozotocin (175 mg/kg) was injected into lean and ob ob mice at 8 wk of age. The influence of this injection upon glucose metabolism, adipose cellularity, pancreatic morphology and immunoreactive insulin (IRI) release from isolated pancreatic islets was measured. The plasma glucose levels before and after an oral glucose load were elevated in lean and decreased in ob ob mice 2 wk after treatment with streptozotocin. By 5 wk after this treatment, a reduced pancreatic islet size, beta cell number and a decreased pancreatic islet IRI release were present in both lean and ob ob mice. At this time, plasma glucose was still elevated in lean, but depressed in ob ob mice and the insulin responsiveness in muscle and adipocytes was unchanged. Hyperglycemia abates in the ob ob mouse as hypersecretion of insulin is diminished, but these observations may not be directly related, since streptozotocin affects key metabolic activities of the liver as well as the pancreatic beta cell. The progression of obesity and status of adipose cellularity are not directly related to hyperinsulinemia, since they are not altered following streptozotocin treatment.",
author = "Batchelor, {Bruce R.} and Stern, {Judith S.} and Johnson, {Patricia R.} and Mahler, {Richard J.}",
year = "1975",
doi = "10.1016/0026-0495(75)90009-8",
language = "English (US)",
volume = "24",
pages = "77--91",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Effects of streptozotocin on glucose metabolism, insulin response, and adiposity in ob ob mice

AU - Batchelor, Bruce R.

AU - Stern, Judith S.

AU - Johnson, Patricia R.

AU - Mahler, Richard J.

PY - 1975

Y1 - 1975

N2 - To determine whether hyperglycemia in the obese hyperglycemic ( ob ob) mouse is related to enhanced activity of the pancreatic beta cell, streptozotocin (175 mg/kg) was injected into lean and ob ob mice at 8 wk of age. The influence of this injection upon glucose metabolism, adipose cellularity, pancreatic morphology and immunoreactive insulin (IRI) release from isolated pancreatic islets was measured. The plasma glucose levels before and after an oral glucose load were elevated in lean and decreased in ob ob mice 2 wk after treatment with streptozotocin. By 5 wk after this treatment, a reduced pancreatic islet size, beta cell number and a decreased pancreatic islet IRI release were present in both lean and ob ob mice. At this time, plasma glucose was still elevated in lean, but depressed in ob ob mice and the insulin responsiveness in muscle and adipocytes was unchanged. Hyperglycemia abates in the ob ob mouse as hypersecretion of insulin is diminished, but these observations may not be directly related, since streptozotocin affects key metabolic activities of the liver as well as the pancreatic beta cell. The progression of obesity and status of adipose cellularity are not directly related to hyperinsulinemia, since they are not altered following streptozotocin treatment.

AB - To determine whether hyperglycemia in the obese hyperglycemic ( ob ob) mouse is related to enhanced activity of the pancreatic beta cell, streptozotocin (175 mg/kg) was injected into lean and ob ob mice at 8 wk of age. The influence of this injection upon glucose metabolism, adipose cellularity, pancreatic morphology and immunoreactive insulin (IRI) release from isolated pancreatic islets was measured. The plasma glucose levels before and after an oral glucose load were elevated in lean and decreased in ob ob mice 2 wk after treatment with streptozotocin. By 5 wk after this treatment, a reduced pancreatic islet size, beta cell number and a decreased pancreatic islet IRI release were present in both lean and ob ob mice. At this time, plasma glucose was still elevated in lean, but depressed in ob ob mice and the insulin responsiveness in muscle and adipocytes was unchanged. Hyperglycemia abates in the ob ob mouse as hypersecretion of insulin is diminished, but these observations may not be directly related, since streptozotocin affects key metabolic activities of the liver as well as the pancreatic beta cell. The progression of obesity and status of adipose cellularity are not directly related to hyperinsulinemia, since they are not altered following streptozotocin treatment.

UR - http://www.scopus.com/inward/record.url?scp=0016438544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016438544&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(75)90009-8

DO - 10.1016/0026-0495(75)90009-8

M3 - Article

C2 - 122852

AN - SCOPUS:0016438544

VL - 24

SP - 77

EP - 91

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 1

ER -